Vident Investment Advisory, LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 147 filers reported holding IMMUNITYBIO INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q1 2023$195,002
-65.1%
107,144
-2.7%
0.01%
-71.4%
Q4 2022$558,197
-42.4%
110,098
-43.6%
0.02%
-34.4%
Q3 2022$969,000
+20.5%
195,127
-9.7%
0.03%
+33.3%
Q2 2022$804,000
-28.9%
215,973
+7.1%
0.02%
-17.2%
Q1 2022$1,131,000
+10.4%
201,588
+19.7%
0.03%
+7.4%
Q4 2021$1,024,000
+7.6%
168,476
+72.3%
0.03%
-6.9%
Q3 2021$952,000
-36.4%
97,754
-6.7%
0.03%
-35.6%
Q2 2021$1,496,000104,7360.04%
Other shareholders
IMMUNITYBIO INC shareholders Q1 2023
NameSharesValueWeighting ↓
ALLEN HOLDING INC /NY 687,571$6,697,0000.99%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$939,0000.34%
Winning Points Advisors, LLC 43,958$428,0000.31%
HARBOURVEST PARTNERS LLC 335,709$3,270,0000.31%
Clearwater Capital Advisors, LLC 147,891$1,440,0000.17%
SHEETS SMITH WEALTH MANAGEMENT 121,923$1,188,0000.16%
Jump Financial, LLC 129,600$1,262,0000.09%
OCCUDO QUANTITATIVE STRATEGIES LP 75,022$731,0000.09%
ClariVest Asset Management LLC 206,332$2,010,0000.06%
Virtus ETF Advisers LLC 14,244$139,0000.06%
View complete list of IMMUNITYBIO INC shareholders